全文获取类型
收费全文 | 36316篇 |
免费 | 3155篇 |
国内免费 | 89篇 |
专业分类
耳鼻咽喉 | 499篇 |
儿科学 | 1051篇 |
妇产科学 | 995篇 |
基础医学 | 4832篇 |
口腔科学 | 893篇 |
临床医学 | 5373篇 |
内科学 | 6671篇 |
皮肤病学 | 603篇 |
神经病学 | 3109篇 |
特种医学 | 1145篇 |
外国民族医学 | 3篇 |
外科学 | 4397篇 |
综合类 | 455篇 |
一般理论 | 29篇 |
预防医学 | 4027篇 |
眼科学 | 625篇 |
药学 | 2294篇 |
3篇 | |
中国医学 | 73篇 |
肿瘤学 | 2483篇 |
出版年
2022年 | 239篇 |
2021年 | 562篇 |
2020年 | 365篇 |
2019年 | 617篇 |
2018年 | 651篇 |
2017年 | 506篇 |
2016年 | 594篇 |
2015年 | 711篇 |
2014年 | 1035篇 |
2013年 | 1433篇 |
2012年 | 2170篇 |
2011年 | 2244篇 |
2010年 | 1209篇 |
2009年 | 1037篇 |
2008年 | 1926篇 |
2007年 | 2000篇 |
2006年 | 1976篇 |
2005年 | 1838篇 |
2004年 | 1916篇 |
2003年 | 1751篇 |
2002年 | 1668篇 |
2001年 | 863篇 |
2000年 | 760篇 |
1999年 | 782篇 |
1998年 | 460篇 |
1997年 | 379篇 |
1996年 | 338篇 |
1995年 | 316篇 |
1994年 | 265篇 |
1993年 | 286篇 |
1992年 | 566篇 |
1991年 | 563篇 |
1990年 | 484篇 |
1989年 | 558篇 |
1988年 | 500篇 |
1987年 | 487篇 |
1986年 | 490篇 |
1985年 | 500篇 |
1984年 | 371篇 |
1983年 | 325篇 |
1982年 | 250篇 |
1981年 | 217篇 |
1979年 | 285篇 |
1978年 | 235篇 |
1977年 | 190篇 |
1976年 | 196篇 |
1975年 | 171篇 |
1974年 | 211篇 |
1973年 | 220篇 |
1972年 | 172篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
31.
Leslee J. Shaw Romalisa Miranda-Peats Piotr Slomka John Friedman Sean W. Hayes Daniel S. Berman Gary V. Heller Marcin Dada William E. Boden Paul Casperson Robert A. O’Rourke Ronald Schwartz William S. Weintraub David J. Maron Spencer King Koon Teo Pamela Hartigan 《Journal of nuclear cardiology》2006,13(5):685-698
Background Stress gated myocardial perfusion single photon emission computed tomography (gSPECT) is increasingly used before and after
intercurrent therapeutic intervention and is the basis for ongoing evaluation in the Department of Veterans Affairs clinical
outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trial.
Methods and Results The COURAGE trial is a North American multicenter randomized clinical trial that enrolled 2287 patients to aggressive medical
therapy vs percutaneous coronary intervention plus aggressive medical therapy. Three COURAGE nuclear substudies have been
designed. The goals of substudy 0 are to examine the diagnostic accuracy of the extent and severity of inducible ischemia
at baseline in COURAGE patients compared with patient symptoms and quantitative coronary angiography and to explore the relationship
between inducible ischemia and the benefit from revascularization when added to medical therapy. Substudy 1 will correlate
the extent and severity of provocative ischemia with the frequency, quality, and instability of recurrent symptoms in postcatheterization
patients. Substudy 2 (n _ 300) will examine the usefulness of sequential gSPECT monitoring 6 to 18 months after therapeutic
intervention. Together, these nuclear substudies will evaluate the role of gSPECT to determine the effectiveness of aggressive
risk-factor modifications, lifestyle interventions, and anti-ischemic medical therapies with or without revascularization
in reducing patients’ ischemic burdens.
Conclusions The unfolding of evidence on the application of gSPECT in trials such as COURAGE defines a new era for nuclear cardiology.
We hope the evidence that emerges from the COURAGE trial will further establish the role of nuclear imaging in the evidence-based
management of patients with stable coronary disease.
The COURAGE trial was supported by the Cooperative Studies Program of the Department of Veterans Affairs Office of Research
and Development in collaboration with the Canadian Institutes of Health Research. Unrestricted research grants were obtained
from Merck & Co; Pfizer Pharmaceuticals; Bristol-Myers Squibb Medical Imaging; Astellas Pharma; Kos Pharmaceuticals; Data
Scope; Astra Zeneca Pharmaceuticals; Astra-Zeneca-Canada; Schering-Plough Coorporation, Ltd; Sanofi-Aventis, Inc; First Horizon;
and GE Healthcare. All industrial funding for this trial was directed through the Department of Veterans Affairs. Additional
funding for this substudy was provided by grants to the Department of Veterans Affairs and Canadian Institutes of Health Research
from Astellas Pharma and Bristol-Myers-Squibb Medical Imaging. 相似文献
32.
Heart failure is reaching epidemic proportions in the United States, causing a constellation of disabling symptoms. Cognitive impairment in people with heart failure may be more common than previously known with multiple etiologies from both the disease process and the treatment. Exemplars from a research study are used to illustrate the perspective of heart failure patients. Given the critical importance of memory deficits on patient education, potential nursing interventions to address the issue of cognitive impairment are described. 相似文献
33.
34.
35.
36.
Pamela D Reiter Adam A Rosenberg Robert Valuck Kathryn Novak 《Journal of perinatology》2005,25(2):125-129
OBJECTIVE: To determine the effectiveness of a 10-day subcutaneous erythropoietin (rHuEpo) course of 300 units per kg per dose plus oral iron compared to oral iron alone in anemic infants during their convalescent phase of illness. STUDY DESIGN: Prospective, randomized trial performed at a 40-bed, teaching, referral, level III, neonatal intensive care unit. Infants with a gestational age at birth of less than 32 weeks, hematocrit of less than or equal to 28% with a corrected reticulocyte count of less than or equal to 5%, postconceptual age of less than 48 weeks or 5 months chronological age, and a diagnosis of anemia of prematurity were considered for inclusion. Major outcome parameters included hematocrit, corrected reticulocyte count and red cell transfusion requirements. RESULTS: A total of 60 infants were enrolled (n=30 per group). Infants randomized to rHuEpo had a significantly higher post-treatment hematocrit and corrected reticulocyte count than infants in the iron only group (p<0.001). There was a trend towards fewer red cell requirements in the rHuEpo group. CONCLUSIONS: The rHuEpo regimen studied here was associated with an acute improvement in hematocrit and corrected reticulocyte counts. This study did not demonstrate a statistically significant decrease in transfusion therapy, in part related to increased subsequent use of rHuEpo in the control group. Taken together, these data demonstrate that this regimen can effectively treat anemia in convalescent premature infants. 相似文献
37.
38.
Clark T 《American Journal of Public Health (New York, N.Y. : 1912)》1926,16(2):194-197
39.
Scalp electrical recording during paralysis: quantitative evidence that EEG frequencies above 20 Hz are contaminated by EMG. 总被引:2,自引:0,他引:2
Emma M Whitham Kenneth J Pope Sean P Fitzgibbon Trent Lewis C Richard Clark Stephen Loveless Marita Broberg Angus Wallace Dylan DeLosAngeles Peter Lillie Andrew Hardy Rik Fronsko Alyson Pulbrook John O Willoughby 《Clinical neurophysiology》2007,118(8):1877-1888
OBJECTIVE: To identify the possible contribution of electromyogram (EMG) to scalp electroencephalogram (EEG) rhythms at rest and induced or evoked by cognitive tasks. METHODS: Scalp EEG recordings were made on two subjects in presence and absence of complete neuromuscular blockade, sparing the dominant arm. The subjects undertook cognitive tasks in both states to allow direct comparison of electrical recordings. RESULTS: EEG rhythms in the paralysed state differed significantly compared with the unparalysed state, with 10- to 200-fold differences in the power of frequencies above 20 Hz during paralysis. CONCLUSIONS: Most of the scalp EEG recording above 20 Hz is of EMG origin. Previous studies measuring gamma EEG need to be re-evaluated. SIGNIFICANCE: This has a significant impact on measurements of gamma rhythms from the scalp EEG in unparalysed humans. It is to be hoped that signal separation methods will be able to rectify this situation. 相似文献
40.